Blood News and Research

RSS

Study: Oligodendrocytes play key role in the distribution of energy-rich molecules

The human brain has about as many neurons as glial cells. These are divided into four major groups: the microglia, the astrocytes, the NG2 glial cells, and the oligodendrocytes.

19 Jan 2021

Mapping antibody reactivity in COVID-19 patients by using multi-coronavirus protein microarray

In an exciting, state-of-the-art study currently available on the medRxiv* preprint server, US researchers created a multi-coronavirus protein microarray containing full-length proteins, peptide libraries, and overlapping protein fragments from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as well as four other human coronaviruses.

19 Jan 2021

ALS study underscores the unique genetics of Maltese population

Malta, a sovereign microstate in the middle of the Mediterranean Sea, has no shortage of sunny beaches, honey-bricked villages and rugged countryside.

19 Jan 2021

Effects of low-fat, plant-based diet compared to low-carb, animal-based diet

People on a low-fat, plant-based diet ate fewer daily calories but had higher insulin and blood glucose levels, compared to when they ate a low-carbohydrate, animal-based diet, according to a small but highly controlled study at the National Institutes of Health.

19 Jan 2021

Study predicts good passive immunotherapy donors to combat COVID-19

A US-based research team determine good candidates for convalescent plasma donations in promoting passive immunity among severely-ill COVID-19 patients.

19 Jan 2021

Kruppel-like factor 2 may be a major determinant of acute respiratory distress syndrome in COVID-19 patients

A study conducted at the University of Chicago, USA, has recently revealed that downregulation of an endothelial transcription factor, Kruppel-like factor 2, by SARS-CoV-2 is responsible for ARDS frequently observed in critically ill COVID-19 patients.

19 Jan 2021

European researchers build Virtual Physiological Human to improve cardiovascular care

European researchers have been building the Virtual Physiological Human (VPH), a full computer model of the body. Through this process, an EU-funded project focused on improving cardiovascular care, and several key results are now being implemented by industry.

19 Jan 2021

Early administration of ivermectin could help reduce viral transmission in COVID-19 patients

A small pilot study suggests that early administration of ivermectin can reduce viral loads and symptom duration in patients with mild COVID-19, which in turn could help reduce viral transmission.

19 Jan 2021

Scientists develop world's first test to accurately predict mood disorders

University of South Australia scientists have developed the world's first test to accurately predict mood disorders in people, based on the levels of a specific protein found in the brain.

19 Jan 2021

FIT test can help identify people with higher risk of colorectal cancer

New research has demonstrated that a simple, cheap test can help identify who is at risk of developing colorectal cancer, aiding early diagnosis and potentially saving lives.

19 Jan 2021

Researchers find potential biomarkers of Parkinson's disease

A research team led by Nagoya University in Japan has found that blood pressure, the hematocrit (the percentage of red blood cells in blood), and serum cholesterol levels change in patients with Parkinson's disease long before the onset of motor symptoms.

18 Jan 2021

E-cigarettes stress and inflame the lungs, impair key regulatory proteins

E-cigarettes stress and inflame the lungs of rats, compromising important regulatory proteins through exposure, according to research recently published in the journal Redox Biology.

18 Jan 2021

Two common blood pressure drugs are not tied to increased risk of COVID-19

Research published in the peer-reviewed journal The Lancet Digital Health and co-led by a UCLA Fielding School of Public Health faculty member has found that two widely used types of blood pressure drugs are not tied to an increased risk of COVID-19 infection or complications.

18 Jan 2021

Researchers develop a technique to modify biological polymers with protein-based biochemical messages

Imagine going to a surgeon to have a diseased or injured organ switched out for a fully functional, laboratory-grown replacement. This remains science fiction and not reality because researchers today struggle to organize cells into the complex 3D arrangements that our bodies can master on their own.

18 Jan 2021

Researchers figure out the precise mechanics involved in cell motility

Theoretical physicists from Berlin teamed up with experimental physicists from Munich to determine the precise mechanics involved in cell motility. The findings were published in the journal Proceedings of the National Academy of Sciences.

18 Jan 2021

Timing may be critical when administering treatment after brain injury

Researchers from the National Institutes of Health have discovered Jekyll and Hyde immune cells in the brain that ultimately help with brain repair but early after injury can lead to fatal swelling, suggesting that timing may be critical when administering treatment.

18 Jan 2021

SARS-CoV-2 RNA in blood serum could predict COVID-19 mortality

Researchers find that the presence of SARS-CoV-2's genetic material in the serum of positive patients could be a sturdy biomarker for predicting COVID-19-related mortality.

18 Jan 2021

Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro

A new study suggests that modified natural killer cells, which express a chimeric antigen receptor using S309 antibody, can bind to and inactivate SARS-CoV-2 spike protein in vitro.

18 Jan 2021

Could procalcitonin indicate bacterial co-infections in COVID-19 patients?

A recent study conducted by Austin Health, Australia, has revealed that the serum level of procalcitonin can be a strong indicator of bacterial co-infection with COVID-19.

18 Jan 2021

Can transgenic mice studies illuminate neurological complications associated with SARS-CoV-2 in humans?

The potentially deadly COVID-19 has not affected animals with corresponding severity. To understand the mechanism of severe disease, animal models have been used. This includes a mouse model that expresses human angiotensin-converting enzyme 2 (hACE2) under the cytokeratin 18 promoter (K18-hACE2). A new study indicates that this may not be a faithful model of human lethal infection with SARS-CoV-2.

18 Jan 2021

Blood News and Research

Study: Oligodendrocytes play key role in the distribution of energy-rich molecules

Mapping antibody reactivity in COVID-19 patients by using multi-coronavirus protein microarray

ALS study underscores the unique genetics of Maltese population

Effects of low-fat, plant-based diet compared to low-carb, animal-based diet

Study predicts good passive immunotherapy donors to combat COVID-19

Kruppel-like factor 2 may be a major determinant of acute respiratory distress syndrome in COVID-19 patients

European researchers build Virtual Physiological Human to improve cardiovascular care

Early administration of ivermectin could help reduce viral transmission in COVID-19 patients

Scientists develop world's first test to accurately predict mood disorders

FIT test can help identify people with higher risk of colorectal cancer

Researchers find potential biomarkers of Parkinson's disease

E-cigarettes stress and inflame the lungs, impair key regulatory proteins

Two common blood pressure drugs are not tied to increased risk of COVID-19

Researchers develop a technique to modify biological polymers with protein-based biochemical messages

Researchers figure out the precise mechanics involved in cell motility

Timing may be critical when administering treatment after brain injury

SARS-CoV-2 RNA in blood serum could predict COVID-19 mortality

Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro

Could procalcitonin indicate bacterial co-infections in COVID-19 patients?

Can transgenic mice studies illuminate neurological complications associated with SARS-CoV-2 in humans?

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News